Hubert H. Humphrey Cancer Center

Robbinsdale, Minnesota 55422

0 studies enrolling now · 18 studies all time

What they study most

Advanced Prostate Cancer, Breast Cancer, Diffuse Large-Cell Lymphoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Hypercalcemia of Malignancy, Lung Cancer, Malignant Ovarian Mixed Epithelial Tumor, Melanoma

Studies at this site

• A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin — Completed
• Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients — Status unconfirmed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma — Completed
• An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma — Completed
• Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma — Stopped early
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed
• SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma — Completed
• Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma — Stopped early
• Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma — Completed
• MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer — Completed